Quantification of pancreatic function using a clinically feasible short endoscopic secretin test

Current diagnostic methods for chronic pancreatitis lack precision, especially in early stages. Clinical and morphological indicators often fail to detect mild or early disease. Prior research has shown that these traditional methods cannot reliably distinguish between healthy individuals and those with early chronic pancreatitis. This gap motivated the search for more accurate diagnostic tools. Non-invasive tests like fecal elastase 1 (FE1) have been used, but their sensitivity and specificity remain limited. No prior work had resolved how to incorporate rapid diagnostic methods into routine endoscopic procedures. The need for a clinically feasible test that can be performed during standard upper endoscopy remains unmet. This paper's contribution is a novel endoscopic approach that may improve diagnostic accuracy in early pancreatic disease.

The study aimed to evaluate a new diagnostic approach for early chronic pancreatitis. The specific problem is the lack of reliable methods to detect mild or early-stage disease. The motivation is to integrate a diagnostic test into routine endoscopic procedures. The researchers sought to determine if a modified endoscopic test could outperform existing methods. They focused on measuring bicarbonate and fecal elastase 1 (FE1) during a short endoscopic secretin test. The goal was to assess how well these markers could differentiate between healthy individuals and those with early chronic pancreatitis. The study also aimed to compare the diagnostic accuracy of these markers. The researchers hoped to establish a clinically feasible and rapid diagnostic method.

The study involved patients with suspected chronic pancreatitis and healthy controls. Participants underwent a modified secretin-stimulated upper endoscopy. Duodenal juice was collected for 15 minutes following stimulation. A modified Layer scoring system was used to classify patients. Fecal elastase 1 levels were also measured. Receiver operating characteristic curves were used to assess diagnostic accuracy. Analysis of variance was applied to compare group discrimination. The researchers evaluated the test's sensitivity, specificity, and predictive values.

Fifty-two patients and 25 controls were included in the study. Twenty-four patients met the modified Layer criteria for CP or non-CP. The overall accuracy of the endoscopic test was 85%, compared to 71% for FE1. The positive predictive value of the endoscopic test was 100%, versus 79% for FE1. The negative predictive value was 80% for the endoscopic test and 69% for FE1. These results suggest the endoscopic test outperforms FE1 in diagnosing pancreatic insufficiency. The test was rapid and easy to perform during routine endoscopy. The researchers observed improved discrimination between groups using the endoscopic method.

The authors concluded that the short endoscopic secretin test is superior to fecal elastase 1 in diagnosing pancreatic insufficiency. The test demonstrated higher accuracy and predictive values in their cohort. The test is rapid and can be incorporated into routine endoscopic procedures. The findings suggest this method may be useful for detecting early or mild chronic pancreatitis. The researchers propose that this test could improve diagnostic precision in clinical practice. They emphasize the test's feasibility during standard upper endoscopy. The results support further evaluation of the endoscopic test in larger populations. The authors suggest that this method may help overcome current diagnostic limitations.